StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
19
This year
2
Publishing Date
2024 - 03 - 12
1
2024 - 02 - 13
1
2023 - 11 - 17
1
2023 - 10 - 10
2
2023 - 09 - 19
1
2023 - 04 - 28
1
2023 - 01 - 11
1
2023 - 01 - 10
1
2022 - 10 - 28
1
2022 - 10 - 26
1
2022 - 10 - 06
1
2022 - 08 - 31
1
2022 - 06 - 29
1
2022 - 03 - 09
1
2021 - 11 - 29
1
2021 - 07 - 29
1
2021 - 05 - 06
1
2021 - 03 - 08
1
Sector
Communications
2
Health technology
13
Manufacturing
3
N/a
1
Producer manufacturing
1
Utilities
1
Tags
Acquire
1
Acquisition
1
Agreement
1
Antibody
1
Application
1
Approval
1
Approved
1
Back
1
Biosimilar
1
Brazil
1
Canada
1
Cancer
2
Cbl-0201
1
Clearance
1
Designation
1
Diabetes
1
Disease
1
Drug
1
Expected
1
Fast track designation
1
Fda
2
Food
1
Glargine
1
Global
2
Granted
1
Growth
4
Harvest
1
Hypercholesterolemia
1
Infection
1
Injection
1
Insulin
1
Jatenzo
1
License
1
Lung cancer
1
Market
7
Mn-001
2
N/a
19
Patent
2
Phase 3
1
Research
1
Schizophrenia
1
Sclerosis
2
Sinusitis
1
Sp-103
1
Study
1
Technology
1
Therapeutics
1
Treatment
19
Trial
1
Water
2
Xtandi
1
Ztlido
1
Entities
Abbott laboratories
1
Abbvie inc.
1
Astellas pharma inc
1
Bausch health companies inc.
1
Biogen inc.
1
Brainstorm cell therapeutics inc.
1
Bright minds biosciences inc
1
Cadiz, inc.
1
Clarus therapeutics holdings, inc.
1
Denali therapeutics inc.
1
Eledon pharmaceuticals inc
1
Eli lilly and company
1
Glaxosmithkline plc
2
Ingersoll rand inc.
1
Karuna therapeutics, inc.
1
Karyopharm therapeutics inc.
1
Medicinova, inc.
2
Medtronic plc
1
Novartis ag
1
Orange
2
Pfizer, inc.
1
Sanofi
1
Sorrento therapeutics, inc.
2
Stryker corporation
1
Teva pharmaceutical industries ltd
2
Viatris inc.
2
Xylem inc.
1
Symbols
ABBV
1
ABT
1
ALPMF
1
ALPMY
1
BCLI
1
BHC
1
BIIB
1
CDZI
1
CRXT
1
CRXTQ
1
DNLI
1
DRUG
1
ELDN
1
FNCTF
2
GLAXF
2
GSK
2
IR
1
KPTI
1
KRTX
1
LLY
1
MDT
1
MNOV
2
NVS
1
NVSEF
1
PFE
1
SNY
1
SNYNF
1
SRNE
2
SYK
1
TEVJF
2
VTRS
2
XYL
1
Exchanges
Nasdaq
17
Nyse
6
Crawled Date
2024 - 03 - 12
1
2024 - 02 - 13
1
2023 - 11 - 17
1
2023 - 10 - 10
2
2023 - 09 - 19
1
2023 - 04 - 28
1
2023 - 01 - 11
1
2023 - 01 - 10
1
2022 - 10 - 28
1
2022 - 10 - 26
1
2022 - 10 - 06
1
2022 - 08 - 31
1
2022 - 06 - 29
1
2022 - 03 - 09
1
2021 - 11 - 29
1
2021 - 07 - 29
1
2021 - 05 - 06
1
2021 - 03 - 08
1
Crawled Time
00:00
129
00:01
3
00:20
24
01:00
97
02:00
38
03:00
26
04:00
19
04:20
16
05:00
29
06:00
66
07:00
66
08:00
67
08:20
6
09:00
77
09:08
3
10:00
64
10:16
6
11:00
309
11:01
3
11:03
3
12:00
755
12:01
12
12:03
16
12:07
4
12:11
3
12:15
67
12:20
136
12:30
119
13:00
628
13:01
3
13:02
4
13:03
14
13:05
4
13:15
41
13:20
153
13:30
110
14:00
443
14:01
12
14:02
4
14:03
6
14:15
22
14:20
60
14:30
73
15:00
233
15:01
7
15:15
9
15:20
37
15:30
56
16:00
156
16:20
32
17:00
158
18:00
131
19:00
137
20:00
148
20:20
17
21:00
189
22:00
185
22:01
5
22:15
7
23:00
166
Source
brightmindsbio.com
1
www.globenewswire.com
4
www.prnewswire.com
13
www.zailaboratory.com
1
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
treatment
crawled time :
04:00
save search
Amyotrophic Lateral Sclerosis Treatment Market size to grow by USD 663.7 million, 42% of market growth is expected in North America, Technavio
Published:
2024-03-12
(Crawled : 04:00)
- prnewswire.com
ELDN
|
$1.85
-7.03%
-7.57%
420K
|
Manufacturing
|
7.51%
|
O:
1.73%
H:
1.7%
C:
-7.39%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-4.21%
|
O:
0.01%
H:
0.0%
C:
0.0%
DNLI
|
$15.98
-3.74%
-3.88%
1.5M
|
Health Technology
|
-26.23%
|
O:
-0.6%
H:
0.74%
C:
-3.66%
BCLI
A
|
$0.5384
4.69%
4.48%
1M
|
Health Technology
|
61.09%
|
O:
-2.43%
H:
2.8%
C:
-4.02%
BIIB
|
$194.39
2.03%
1.99%
1.6M
|
Health Technology
|
-15.51%
|
O:
-0.32%
H:
0.18%
C:
-0.86%
expected
sclerosis
treatment
growth
market
Sinusitis Treatment Market Global Trends, Opportunity, and Forecast, 2018-2028F - Increasing Patient Preference for Minimally Invasive Procedures
Published:
2024-02-13
(Crawled : 04:00)
- prnewswire.com
SYK
|
$325.43
-0.62%
0.0%
1.8M
|
Health Technology
|
-4.59%
|
O:
-0.35%
H:
0.41%
C:
-0.03%
MDT
|
$79.48
0.37%
-0.29%
6.7M
|
Health Technology
|
-6.57%
|
O:
-0.59%
H:
0.51%
C:
-1.16%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
-3.81%
|
O:
0.94%
H:
0.0%
C:
0.0%
treatment
global
sinusitis
market
Pfizer and Astellas' XTANDI® Approved by U.S. FDA in Earlier Prostate Cancer Treatment Setting
Published:
2023-11-17
(Crawled : 04:00)
- prnewswire.com
ALPMF
|
$9.17
43.47%
16K
|
Health Technology
|
-15.95%
|
O:
0.04%
H:
0.0%
C:
0.0%
ALPMY
|
$9.47
-1.11%
520K
|
Manufacturing
|
-17.89%
|
O:
1.38%
H:
1.79%
C:
1.79%
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-12.66%
|
O:
0.5%
H:
0.3%
C:
0.0%
xtandi
fda
approved
cancer
treatment
Water and Wastewater Treatment Equipment Market to grow by USD 22.85 billion during 2022-2027 | Increasing global concerns regarding water scarcity to drive the growth - Technavio
Published:
2023-10-10
(Crawled : 04:00)
- prnewswire.com
XYL
|
$127.84
0.53%
0.0%
2.2M
|
Producer Manufacturing
|
40.34%
|
O:
0.35%
H:
1.6%
C:
0.59%
IR
|
News
|
$88.4
-0.64%
0.0%
2.5M
|
Producer Manufacturing
|
37.91%
|
O:
0.08%
H:
1.75%
C:
0.84%
water
treatment
global
growth
market
Karuna Therapeutics Submits New Drug Application to U.S. Food and Drug Administration for KarXT for the Treatment of Schizophrenia
Published:
2023-10-10
(Crawled : 04:00)
- zailaboratory.com
KRTX
|
$329.83
0.0%
1.9M
|
Health Technology
|
90.66%
|
O:
0.93%
H:
1.45%
C:
0.77%
drug
food
treatment
schizophrenia
application
therapeutics
Caliway Announces the Completion of Subject Recruitment in the CBL-0201EFP Phase 2-stage 2 Study Evaluating the CBL-514 in Cellulite Treatment
Published:
2023-09-19
(Crawled : 04:00)
- prnewswire.com
FNCTF
|
News
|
$11.0354
-20.84%
320
|
Communications
|
-4.46%
|
O:
3.29%
H:
0.0%
C:
0.0%
cbl-0201
treatment
study
Post Harvest Treatment Market size to grow by USD 842.28 million from 2022 to 2027, The increasing demand for fresh produce to drive the market growth - Technavio
Published:
2023-04-28
(Crawled : 04:00)
- prnewswire.com
FNCTF
|
News
|
$11.0354
-20.84%
320
|
Communications
|
-13.45%
|
O:
1.28%
H:
0.0%
C:
0.0%
harvest
treatment
growth
market
MediciNova Receives a Notice of Allowance for a New Patent Covering MN-001 and MN-002 for the Treatment of Scleroderma and Systemic Sclerosis in Canada
Published:
2023-01-11
(Crawled : 04:00)
- globenewswire.com
MNOV
|
$1.395
-0.36%
-0.36%
18K
|
Health Technology
|
-43.27%
|
O:
4.9%
H:
0.39%
C:
-1.17%
mn-001
treatment
patent
canada
sclerosis
MediciNova Receives a Notice of Allowance for a New Patent Covering MN-001 and MN-002 for the Treatment of Hypertriglyceridemia, Hypercholesterolemia, and Hyperlipoproteinemia in Brazil
Published:
2023-01-10
(Crawled : 04:00)
- globenewswire.com
MNOV
|
$1.395
-0.36%
-0.36%
18K
|
Health Technology
|
-43.03%
|
O:
0.41%
H:
2.04%
C:
0.0%
mn-001
treatment
patent
brazil
hypercholesterolemia
Tolmar Announces Acquisition of JATENZO® (testosterone undecanoate) for the Treatment of Hypogonadism to Expand its Market Leading Urology Portfolio
Published:
2022-10-28
(Crawled : 04:00)
- prnewswire.com
CRXTQ
|
$0.0014
0
|
n/a
|
Email alert
Add to watchlist
CRXT
|
$0.0475
|
|
Email alert
Add to watchlist
jatenzo
treatment
acquisition
market
CADIZ INC. ANNOUNCES AGREEMENT TO ACQUIRE WATER TREATMENT TECHNOLOGY COMPANY ATEC SYSTEMS
Published:
2022-10-26
(Crawled : 04:00)
- prnewswire.com
CDZI
P
|
$2.25
0.0%
260K
|
Utilities
|
25.7%
|
O:
0.0%
H:
3.35%
C:
-0.56%
water
treatment
acquire
technology
agreement
Sexually Transmitted Diseases (STD) Treatment Market to Record a CAGR of 4.27%, Increasing Prevalence Of STDs to Boost Market Growth - Technavio
Published:
2022-10-06
(Crawled : 04:00)
- prnewswire.com
GLAXF
|
News
|
$20.2
-14.18%
510
|
Health Technology
|
32.59%
|
O:
-2.53%
H:
0.0%
C:
0.0%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
30.71%
|
O:
-1.25%
H:
0.53%
C:
-0.1%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
16.1%
|
O:
-0.38%
H:
0.14%
C:
-1.75%
treatment
growth
market
Scilex Holding Company, a Sorrento Company, Announces That the FDA Has Granted Fast Track Designation for SP-103 (Lidocaine Topical System) 5.4%, Next Generation Triple Strength Formulation of ZTlido®, for the Treatment of Acute Low Back Pain (LBP)
Published:
2022-08-31
(Crawled : 04:00)
- globenewswire.com
SRNE
|
$0.024
-8.85%
57K
|
Health Technology
|
-98.97%
|
O:
5.15%
H:
2.94%
C:
0.49%
sp-103
ztlido
treatment
fda
designation
back
granted
fast track designation
Herpes Treatment Market size to grow by USD 723.04 Mn | Market Research Insights highlight increasing prevalence of herpes infection as Key Driver | Technavio
Published:
2022-06-29
(Crawled : 04:00)
- prnewswire.com
TEVJF
|
News
|
$12.37
-24.22%
380
|
Health Technology
|
48.32%
|
O:
-9.17%
H:
0.0%
C:
0.0%
GLAXF
|
News
|
$20.2
-14.18%
510
|
Health Technology
|
-26.51%
|
O:
-0.95%
H:
1.01%
C:
-3.54%
VTRS
A
|
$11.25
1.17%
1.16%
4.7M
|
Health Technology
|
1.31%
|
O:
-1.49%
H:
0.09%
C:
-1.19%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
10.48%
|
O:
-0.68%
H:
0.0%
C:
0.0%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
-26.64%
|
O:
0.3%
H:
1.08%
C:
0.67%
BHC
|
$8.69
1.05%
0.0%
2.9M
|
Health Technology
|
-0.69%
|
O:
0.57%
H:
0.57%
C:
-3.3%
treatment
research
infection
market
Sinusitis Treatment Market to Rise at CAGR of 3.6% during Forecast Period, Observes TMR Study
Published:
2022-03-09
(Crawled : 04:00)
- prnewswire.com
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
179.64%
|
O:
1.37%
H:
1.71%
C:
-0.19%
treatment
Bright Minds Biosciences Provides Scientific Update on its Novel 5-HT2A Psychedelic Program for the Treatment of Mental Diseases
Published:
2021-11-29
(Crawled : 04:00)
- brightmindsbio.com
DRUG
|
$1.25
-6.61%
11K
|
Manufacturing
|
-69.98%
|
O:
12.11%
H:
2.81%
C:
-1.73%
disease
treatment
Viatris Inc. and Biocon Biologics Receive Historic Approval for First Interchangeable Biosimilar Semglee® (insulin glargine-yfgn injection) for the Treatment of Diabetes
Published:
2021-07-29
(Crawled : 04:00)
- prnewswire.com
VTRS
A
|
$11.25
1.17%
1.16%
4.7M
|
Health Technology
|
-20.94%
|
O:
2.88%
H:
0.27%
C:
-2.39%
diabetes
treatment
injection
insulin
approval
biosimilar
glargine
Antengene Announces Selinexor Added to Multiple Treatment Regimens in 2021 CSCO Guidelines
Published:
2021-05-06
(Crawled : 04:00)
- prnewswire.com
KPTI
|
$1.16
-9.38%
-10.34%
1.4M
|
Health Technology
|
-85.57%
|
O:
0.37%
H:
1.11%
C:
0.0%
treatment
Lee’s Pharmaceutical Announces its Anti-PD-L1 Antibody Socazolimab, Licensed From Sorrento Therapeutics, Receives Clearance to Start Phase 3 Trial as a First-line Treatment of Extensive-stage Small-Cell Lung Cancer
Published:
2021-03-08
(Crawled : 04:00)
- globenewswire.com
SRNE
|
$0.024
-8.85%
57K
|
Health Technology
|
-99.77%
|
O:
3.38%
H:
0.76%
C:
-4.25%
treatment
lung cancer
cancer
antibody
license
phase 3
trial
clearance
Gainers vs Losers
67%
33%
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.